![Christopher Yea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Yea
Corporate Officer/Principal presso
KALVISTA PHARMA
Profilo
Christopher M.
Yea was the founder of Vantia Ltd. and held the title of Chief Operating Officer from 2008 to 2015.
Dr. Yea is currently the Chief Development Officer at KalVista Pharmaceuticals Ltd. since 2015 and at KalVista Pharmaceuticals, Inc. since 2016.
Education includes undergraduate and doctorate degrees from the University of Bristol.
Posizioni attive di Christopher Yea
| Società | Posizione | Inizio |
|---|---|---|
| KALVISTA PHARMA | Corporate Officer/Principal | 01/11/2016 |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Corporate Officer/Principal | 01/11/2015 |
Precedenti posizioni note di Christopher Yea
| Società | Posizione | Fine |
|---|---|---|
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecule agonists of vasopressin receptors | Fondatore | 01/11/2015 |
Formazione di Christopher Yea
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecule agonists of vasopressin receptors | Commercial Services |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
